Salvage extracorporeal membrane oxygenation in induction-associated acute respiratory distress syndrome in acute leukemia patients: A case series

Abstract

Background:

The prognosis of hematologic malignancies has improved over the past three decades. However, the prognosis in hematologic malignancies with severe acute respiratory distress syndrome has remained poor. Initial reports regarding the utility of extracorporeal membrane oxygenation in hematologic malignancies have been controversial, with limited evaluations of acute leukemia patients supported by extracorporeal membrane oxygenation.

Methods:

We conducted a retrospective review of patients with acute leukemia who developed acute respiratory distress syndrome requiring veno-venous extracorporeal membrane oxygenation support at our facility from July 2015 through August 2017.

Results:

Four cases of acute myelogenous leukemia with respiratory failure and acute respiratory distress syndrome treated with veno-venous extracorporeal membrane oxygenation while undergoing induction chemotherapy were identified. All patients completed induction therapy with addition of extracorporeal membrane oxygenation support, with two patients dying secondary to their acute leukemia and the other two surviving to allogeneic hematopoietic stem cell transplant. Overall, 75% (three of four) survived to decannulation with a 1-year survival rate following extracorporeal membrane oxygenation of 50% (two of four).

Conclusion:

Currently, the use of extracorporeal membrane oxygenation in patients with hematologic malignancies who develop severe acute respiratory distress syndrome remains controversial. Although extracorporeal membrane oxygenation in post-allogeneic hematopoietic stem cell transplant is associated with poorer outcomes, our data suggest that salvage extracorporeal membrane oxygenation support is a viable option to manage moderate to severe acute respiratory distress syndrome while completing therapeutic chemotherapy and following in the peri-induction phase of acute leukemia.

Keywords

Acute respiratory distress syndrome acute myelogenous leukemia extracorporeal membrane oxygenation leukemia

Get full access to this article

View all access options for this article.

References

Yeo

Kim

et al . Prognostic factors in critically ill patients with hematologic malignancies admitted to the intensive care unit. J Crit Care 2012; 27: 739.e1–739.e6.

Rabe

Mey

Paashaus

et al . Outcome of patients with acute myeloid leukemia and pulmonary infiltrates requiring invasive mechanical ventilation—a retrospective analysis. J Crit Care 2004; 19: 29–35.

Azoulay

Lemiale

Mokart

et al . Acute respiratory distress syndrome in patients with malignancies. Intensive Care Med 2014; 40: 1106–1114.

Schmidt

Schellongowski

Patroniti

et al . Six-month outcome of immunocompromised severe ARDS patients rescued by ECMO. An international multicenter retrospective study. Am J Respir Crit Care Med. Epub ahead of print 3 January 2018. DOI: 10.1164/rccm.201708-1761OC.

Chaoui

Legrand

Roche

et al . Incidence and prognostic value of respiratory events in acute leukemia. Leukemia 2004; 18: 670–675.

Azoulay

Pène

Darmon

et al . Managing critically ill hematology patients: time to think differently. Blood Rev 2015; 29: 359–367.

Kraguljac

Croucher

Christian

et al . Outcomes and predictors of mortality for patients with acute leukemia admitted to the intensive care unit. Can Respir J 2016; 2016: 3027656.

Roze des Ordons

Chan

Mirza

et al . Clinical characteristics and outcomes of patients with acute myelogenous leukemia admitted to intensive care: a case-control study. BMC Cancer 2010; 10: 516.

Lagier

Platon

Chow-Chine

et al . Severity of Acute Respiratory Distress Syndrome in haematology patients: long-term impact and early predictive factors. Anaesthesia 2016; 71: 1081–1090.

10.

Al Ameri

Koller

Kantarjian

et al . Acute pulmonary failure during remission induction chemotherapy in adults with acute myeloid leukemia or high-risk myelodysplastic syndrome. Cancer 2009; 116: 93–97.

11.

Wohlfarth

Ullrich

Staudinger

et al . Extracorporeal membrane oxygenation in adult patients with hematologic malignancies and severe acute respiratory failure. Crit Care 2014; 18: R20.

12.

Kang

Rhee

Lee

et al . Clinical outcomes of extracorporeal membrane oxygenation support in patients with hematologic malignancies. Korean J Intern Med 2015; 30: 478–488.

13.

Wohlfarth

Beutel

Lebiedz

et al . Characteristics and outcome of patients after allogeneic hematopoietic stem cell transplantation treated with extracorporeal membrane oxygenation for acute respiratory distress syndrome. Crit Care Med 2017; 45: e500–e507.

14.

Schmidt

Bréchot

Combes

et al . Ten situations in which ECMO is unlikely to be successful. Intensive Care Med 2016; 42: 750–752.

15.

Moreau

A-S

Lengline

Seguin

et al . Respiratory events at the earliest phase of acute myeloid leukemia. Leuk Lymphoma 2014; 55: 2556–2563.

16.

Al-Dorzi

Al Orainni

Al Eid

et al . Characteristics and predictors of mortality of patients with hematologic malignancies requiring invasive mechanical ventilation. Ann Thorac Med 2017; 12: 259–265.

17.

Lemiale

Resche-Rigon

Mokart

et al . Acute respiratory failure in patients with hematological malignancies: outcomes according to initial ventilation strategy. A groupe de recherche respiratoire en réanimation onco-hématologique (Grrr-OH) Study. Ann Intensive Care 2015; 5: 28.

18.

Rosner

Capasso

Perazella

et al . Acute kidney injury and electrolyte disorders in the critically ill patient with cancer. Curr Opin Crit Care 2017; 23: 475–483.

19.

Shekar

Fraser

Smith

et al . Pharmacokinetic changes in patients receiving extracorporeal membrane oxygenation. J Crit Care 2012; 27: 741.e9–741.e18.

20.

Murphy

Hockings

Andrews

et al . Extracorporeal membrane oxygenation–hemostatic complications. Transfus Med Rev 2015; 29: 90–101.